Mathematics
Cancer
100%
Drug Resistance
69%
Resistance
67%
Therapy
59%
Tumor
54%
Drugs
44%
Mutation
43%
Cell
36%
Mutant
31%
Leukemia
30%
Recurrence
29%
Probabilistic Methods
28%
Schedule
27%
Timing
26%
Collocation Method
25%
Spatial Model
23%
Model
19%
Fitness
19%
Clone
17%
Carcinogenesis
17%
Sensitivity Analysis
16%
Phenotype
15%
Progression
14%
Hypoxia
13%
Cell Population
13%
Strategy
12%
Colorectal Cancer
12%
Mathematical Model
12%
Polynomial Chaos
12%
Cell Proliferation
11%
Stem Cells
11%
Collocation
10%
Power System
10%
Driver
10%
Stochastic Simulation
10%
Stochastic Model
10%
Rare Events
9%
Material Properties
9%
Amplification
9%
Stochastic Analysis
9%
Acute
8%
Screening
8%
Imaging
8%
Pathway
8%
Multidimensional Integration
8%
Radiation
8%
Voter Model
8%
Medicine & Life Sciences
Neoplasms
63%
Drug Resistance
49%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
28%
Epigenomics
27%
Appointments and Schedules
26%
Pharmaceutical Preparations
24%
Imatinib Mesylate
24%
Mutation
23%
Protein-Tyrosine Kinases
23%
Erlotinib Hydrochloride
21%
Recurrence
21%
Therapeutics
20%
Non-Small Cell Lung Carcinoma
19%
Preclinical Drug Evaluations
19%
Population
18%
Theoretical Models
16%
ErbB Receptors
16%
Population Dynamics
15%
Growth
12%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
12%
Natural Science Disciplines
11%
Phenotype
11%
Carcinogenesis
11%
O-(6)-methylguanine
11%
Myeloid Progenitor Cells
10%
Organoids
10%
Temozolomide
9%
Genetic Heterogeneity
9%
Pharmacokinetics
9%
Methyltransferases
8%
Prodrugs
8%
Granulocyte Colony-Stimulating Factor
8%
Cell Division
8%
Phosphotransferases
8%
Cell Line
8%
Head and Neck Neoplasms
7%
Glioblastoma
7%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7%
Tobacco
7%
Drug Administration Schedule
7%
Ovarian Neoplasms
7%
Methylation
7%
Parturition
7%
Colorectal Neoplasms
6%
Clone Cells
6%
Radiation
6%
MicroRNAs
6%
TH 302
6%
Kinetics
6%
Lung Neoplasms
6%
Agriculture & Biology
neoplasms
86%
drug resistance
57%
therapeutics
55%
cancer therapy
36%
myeloid leukemia
33%
drugs
30%
mutation
29%
epigenetics
24%
mathematical models
21%
neoplasm cells
20%
cells
17%
carcinogenesis
14%
resistance mechanisms
13%
statistical inference
12%
neoplasm progression
11%
granulocyte colony-stimulating factor
11%
phosphotransferases (kinases)
11%
lymphocytic leukemia
10%
colorectal neoplasms
9%
caves
8%
phenotype
8%
stem cells
7%
tissues
7%
mutation accumulation
7%
mutation rate
7%
death
7%
tyrosine
7%
hypoxia
7%
disease progression
7%
cell proliferation
7%
image analysis
6%
clones
6%
kinetics
6%
screening
5%
branching
5%
antineoplastic agents
5%
drug toxicity
5%